gynecologic benign diseases
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who are diagnosed as uterine fibroids, adenomyosis, endometriosis, endometrial polyps, or ovarian cysts by gynecological practice with and without Gonadotropin releasing hormone agonist/antagonist. Patients during non-ovarian stimulation cycles. Patients during controlled ovarian hyperstimulation cycles.
Exclusion criteria
Exclusion criteria: Patients medicated with antiplatelets or anticoagulants. Patients affected by venous thromboembolism. Patients complicated with diseases involving platelets, coagulation, fibrinolysis, anticoagulation, or antifibrinolysis system. Patients with anemia (Hb< 8.0 g/dL). Patients after menopause. Patients with serious liver disease (or AST <= 100 U/L). Patients with severe renal disease (or serum creatinine <= 1.3 mg/dL). Pregnant women. Women during lactation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The parameters of Rotational thromboelastometry and Endogenous thrombin potential-based activated protein C sensitivity ratio. | — |
Countries
Japan
Contacts
Hamamatsu University School of Medicine Department of Obstetrics and Gynecology